Tiffany Butterfield

Dr. Tiffany Butterfield

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
JAJoshua J. Anzinger
Joshua J. Anzinger
TBTiffany Butterfield
Tiffany Butterfield
TAThomas Angelovich
Thomas Angelovich
SCSuzanne M. Crowe
Suzanne M. Crowe
CPClovis Palmer
Clovis Palmer
Combined antiretroviral therapy (cART) extends the lifespan and the quality of life for HIV-infected persons but does not completely eliminate chronic immune activation and inflammation. The low level of chronic immune activation persisting during cART-treated HIV infection is associated with the development of diseases which usually occur in the elderly. Although T-cell activation has been extensively examined in the context of cART-treated HIV infection, monocyte activation is only beginning to be recognized as an important source of inflammation in this context. Here we examine markers and sources of monocyte activation during cART-treated HIV infection and discuss the role of monocytes during cardiovascular disease, HIV-associated neurocognitive disorder, and innate immune aging.

22 October 2019 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
THTianyu He
Tianyu He
CXCuiling Xu
Cuiling Xu
NKNoah Krampe
Noah Krampe
SDStephanie M. Dillon
Stephanie M. Dillon
PSPaola Sette
Paola Sette
IPIvona Pandrea
Ivona Pandrea
Consuming a high-fat diet (HFD) is a risk factor for obesity and diabetes; both of these diseases are also associated with systemic inflammation, similar to HIV infection. A HFD induces intestinal dysbiosis and impairs liver function and coagulation, with a potential negative impact on HIV/SIV pathogenesis. We administered a HFD rich in saturated fats and cholesterol to nonpathogenic (African green monkeys) and pathogenic (pigtailed macaques) SIV hosts. The HFD had a negative impact on SIV disease progression in both species. Thus, increased cell-associated SIV DNA and RNA occurred in the HFD-receiving nonhuman primates, indicating a potential reservoir expansion. The HFD induced prominent immune cell infiltration in the adipose tissue, an important SIV reservoir, and heightened systemic immune activation and inflammation, altering the intestinal immune environment and triggering gut damage and microbial translocation. Furthermore, HFD altered lipid metabolism and HDL oxidation and also induced liver steatosis and fibrosis. These metabolic disturbances triggered incipient atherosclerosis and heightened cardiovascular risk in the SIV-infected HFD-receiving nonhuman primates. Our study demonstrates that dietary intake has a discernable impact on the natural history of HIV/SIV infections and suggests that dietary changes can be used as adjuvant approaches for HIV-infected subjects, to reduce inflammation and the risk of non-AIDS comorbidities and possibly other infectious diseases.

22 October 2008 in Cytometry Part A
Verified
Journal Article
Open access
PDF file
MPMelissa L. Precopio
Melissa L. Precopio
TBTiffany Butterfield
Tiffany Butterfield
JCJoseph P. Casazza
Joseph P. Casazza
SLSusan J. Little
Susan J. Little
DRDouglas D. Richman
Douglas D. Richman
MRMario Roederer
Mario Roederer
Mapping T‐cell epitopes for a pathogen or vaccine requires a complex method for screening hundreds to thousands of peptides with a limited amount of donor sample. We describe an optimized deconvolution process by which peptides are pooled in a matrix format to minimize the number of tests required to identify peptide epitopes. Four peptide pool matrices were constructed to deconvolute the HIV‐specific T‐cell response in three HIV‐infected individuals. ELISpot assays were used to map peptide antigens. Many HIV peptides were mapped in all three individuals. However, there were several challenges and limitations associated with the deconvolution process. Peptides that induced low‐frequency responses or were masked by peptide competition within a given pool were not identified, because they did not meet the threshold criteria for a positive response. Also, amino acid sequence variation limited the ability of this method to map autologous HIV peptides. Alternative analysis strategies and revisions to the original matrix optimizations are presented that address ways to increase peptide identification. This optimized deconvolution method allows for efficient mapping of T‐cell peptide epitopes. It is rapid, powerful, efficient, and unrestricted by HLA type. Published 2008 Wiley‐Liss, Inc.

12 August 2016 in Journal of Visualized Experiments
Verified
Journal Article
Open access
PDF file
CPClovis Palmer
Clovis Palmer
JAJoshua J. Anzinger
Joshua J. Anzinger
TBTiffany Butterfield
Tiffany Butterfield
JMJoseph M. McCune
Joseph M. McCune
SCSuzanne M. Crowe
Suzanne M. Crowe
Monocytes are integral components of the human innate immune system that rely on glycolytic metabolism when activated. We describe a...

30 June 2009 in Journal of Separation Science
Verified
Journal Article
Closed access
PDF file
SWScott A. Weisenberg
Scott A. Weisenberg
TBTiffany Butterfield
Tiffany Butterfield
SFSteven M. Fischer
Steven M. Fischer
KRKyu Y. Rhee
Kyu Y. Rhee

14 January 2017 in AIDS
Verified
Journal Article
Closed access
TBTiffany Butterfield
Tiffany Butterfield
DHDavid B. Hanna
David B. Hanna
RKRobert C. Kaplan
Robert C. Kaplan
JKJorge R. Kizer
Jorge R. Kizer
HDHelen G. Durkin
Helen G. Durkin
JAJoshua Anzinger
Joshua Anzinger
Objective: People living with HIV (PLWH) have chronic immune activation and increased cardiovascular disease (CVD) risk. Activation of monocytes and T lymphocytes causes upregulation of glucose transporter-1 (GLUT1) for efficient function. PLWH have an increased percentage of GLUT1-expressing monocytes and T lymphocytes, but it is unclear if these cells are associated with CVD. We evaluated the expression of GLUT1 and CD38 on monocyte and T lymphocyte populations from HIV-infected women with subclinical CVD. Methods: Participants with more than 75th percentile (n = 15) and less than 25th percentile (n = 15) age-adjusted intima-media thickness (IMT) at the right common carotid artery and bifurcation were identified from the Women's Interagency HIV Study. Groups were matched by age, race/ethnicity, smoking status, and CD4+ cell count. All women were receiving suppressive antiretroviral therapy except for one high and one low IMT participant. Monocyte and T lymphocyte populations were evaluated for GLUT1 and CD38 expression using flow cytometry. Results: Intermediate monocytes from high IMT women had significantly increased expression of GLUT1 (310 MFI vs. 210 MFI, P = 0.024) (66.4% vs. 48.5%, P = 0.031) and CD38 (339 MFI vs. 211 MFI, P = 0.002) (10.5% vs. 3.8%, P = 0.0002) compared with women with low IMT. High and low IMT participants showed no differences in GLUT1 or CD38 expression on classical monocytes, nonclassical monocytes, CD4+ and CD8+ T lymphocytes. Conclusion: GLUT1-expressing intermediate monocytes are elevated in HIV-infected women with subclinical CVD. These cells may contribute to development of CVD in PLWH and could be a novel target to limit inflammation.